Kim Su-Young, Park Hye Yun, Jeong Byeong-Ho, Jeon Kyeongman, Huh Hee Jae, Ki Chang-Seok, Lee Nam Yong, Han Seung-Jung, Shin Sung Jae, Koh Won-Jung
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
BMC Infect Dis. 2015 Sep 30;15:406. doi: 10.1186/s12879-015-1140-4.
Mycobacterium intracellulare is a major cause of Mycobacterium avium complex lung disease in many countries. Molecular studies have revealed several new Mycobacteria species that are closely related to M. intracellulare. The aim of this study was to re-identify and characterize clinical isolates from patients previously diagnosed with M. intracellulare lung disease at the molecular level.
Mycobacterial isolates from 77 patients, initially diagnosed with M. intracellulare lung disease were re-analyzed by multi-locus sequencing and pattern of insertion sequences.
Among the 77 isolates, 74 (96 %) isolates were designated as M. intracellulare based on multigene sequence-based analysis. Interestingly, the three remaining strains (4 %) were re-identified as "Mycobacterium indicus pranii" according to distinct molecular phylogenetic positions in rpoB and hsp65 sequence-based typing. In hsp65 sequevar analysis, code 13 was found in the majority of cases and three unreported codes were identified. In 16S-23S rRNA internal transcribed spacer (ITS) sequevar analysis, all isolates of both species were classified within the Min-A ITS sequevar. Interestingly, four of the M. intracellulare isolates harbored IS1311, a M. avium-specific element. Two of three patients infected with "M. indicus pranii" had persistent positive sputum cultures after antibiotic therapy, indicating the clinical relevance of this study.
This analysis highlights the importance of precise identification of clinical isolates genetically close to Mycobacterium species, and suggests that greater attention should be paid to nontuberculous mycobacteria lung disease caused by "M. indicus pranii".
胞内分枝杆菌是许多国家鸟分枝杆菌复合群肺病的主要病因。分子研究揭示了几种与胞内分枝杆菌密切相关的新分枝杆菌物种。本研究的目的是在分子水平上重新鉴定和表征先前诊断为胞内分枝杆菌肺病患者的临床分离株。
对77例最初诊断为胞内分枝杆菌肺病患者的分枝杆菌分离株进行多位点测序和插入序列模式的重新分析。
在77株分离株中,基于多基因序列分析,74株(96%)分离株被鉴定为胞内分枝杆菌。有趣的是,根据基于rpoB和hsp65序列分型的不同分子系统发育位置,其余三株(4%)菌株被重新鉴定为“印度普拉尼分枝杆菌”。在hsp65序列变异分析中,大多数病例中发现了代码13,并鉴定出三个未报告的代码。在16S - 23S rRNA内部转录间隔区(ITS)序列变异分析中,两个物种的所有分离株均归类于Min - A ITS序列变异。有趣的是,四株胞内分枝杆菌分离株携带鸟分枝杆菌特异性元件IS1311。三名感染“印度普拉尼分枝杆菌”的患者中有两名在抗生素治疗后痰培养持续呈阳性,表明了本研究的临床相关性。
该分析强调了精确鉴定与分枝杆菌物种基因相近的临床分离株的重要性,并建议应更加关注由“印度普拉尼分枝杆菌”引起的非结核分枝杆菌肺病。